<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    16754904
   </pmid>
   <datecreated>
    <year>
     2006
    </year>
    <month>
     06
    </month>
    <day>
     06
    </day>
   </datecreated>
   <datecompleted>
    <year>
     2006
    </year>
    <month>
     06
    </month>
    <day>
     08
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2009
    </year>
    <month>
     11
    </month>
    <day>
     18
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Electronic">
      1488-2329
     </issn>
     <journalissue citedmedium="Internet">
      <volume>
       174
      </volume>
      <issue>
       12
      </issue>
      <pubdate>
       <year>
        2006
       </year>
       <month>
        Jun
       </month>
       <day>
        6
       </day>
      </pubdate>
     </journalissue>
     <title>
      CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
     </title>
     <isoabbreviation>
      CMAJ
     </isoabbreviation>
    </journal>
    <articletitle>
     Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis.
    </articletitle>
    <pagination>
     <medlinepgn>
      1737-42
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext label="BACKGROUND" nlmcategory="BACKGROUND">
      In a recently published meta-analysis, investigators asserted that beta-blockers should not be used to treat hypertension. Because the pathophysiology of hypertension differs in older and younger patients, we designed this meta-analysis to clarify the efficacy of beta-blockers in different age groups. The primary outcome was a composite of stroke, myocardial infarction and death.
     </abstracttext>
     <abstracttext label="METHODS" nlmcategory="METHODS">
      We identified randomized controlled trials that evaluated the efficacy of beta-blockers as first-line therapy for hypertension in preventing major cardiovascular outcomes. Both authors independently evaluated the eligibility of all trials. Trials enrolling older (mean age at baseline &gt; or = 60 years) patients were separated from those enrolling younger (mean age &lt; 60 years) patients. Data were pooled using a random effects model.
     </abstracttext>
     <abstracttext label="RESULTS" nlmcategory="RESULTS">
      Our analysis incorporated data from 145 811 participants in 21 hypertension trials. In placebo-controlled trials, beta-blockers reduced major cardiovascular outcomes in younger patients (risk ratio [RR] 0.86, 95% confidence interval [CI] 0.74-0.99, based on 794 events in 19 414 patients) but not in older patients (RR 0.89, 95% CI 0.75-1.05, based on 1115 events in 8019 patients). In active comparator trials, beta-blockers demonstrated similar efficacy to other antihypertensive agents in younger patients (1515 events in 30 412 patients, RR 0.97, 95% CI 0.88-1.07) but not in older patients (7405 events in 79 775 patients, RR 1.06, 95% CI 1.01-1.10), with the excess risk being particularly marked for strokes (RR 1.18, 95% CI 1.07-1.30).
     </abstracttext>
     <abstracttext label="INTERPRETATION" nlmcategory="CONCLUSIONS">
      beta-blockers should not be considered first-line therapy for older hypertensive patients without another indication for these agents; however, in younger patients beta-blockers are associated with a significant reduction in cardiovascular morbidity and mortality.
     </abstracttext>
    </abstract>
    <affiliation>
     Division of General Internal Medicine, University of British Columbia.
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Khan
      </lastname>
      <forename>
       Nadia
      </forename>
      <initials>
       N
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       McAlister
      </lastname>
      <forename>
       Finlay A
      </forename>
      <initials>
       FA
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Meta-Analysis
     </publicationtype>
     <publicationtype>
      Research Support, Non-U.S. Gov't
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     Canada
    </country>
    <medlineta>
     CMAJ
    </medlineta>
    <nlmuniqueid>
     9711805
    </nlmuniqueid>
    <issnlinking>
     0820-3946
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Adrenergic beta-Antagonists
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Placebos
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    AIM
   </citationsubset>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="Cites">
     <refsource>
      Stroke. 1993 Apr;24(4):543-8
     </refsource>
     <pmid version="1">
      8465360
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      JAMA. 1982 Oct 22;248(16):2004-11
     </refsource>
     <pmid version="1">
      6750167
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      JAMA. 1998 Jun 17;279(23):1903-7
     </refsource>
     <pmid version="1">
      9634263
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      BMJ. 1998 Sep 12;317(7160):713-20
     </refsource>
     <pmid version="1">
      9732338
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Circulation. 1997 Jul 1;96(1):308-15
     </refsource>
     <pmid version="1">
      9236450
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Acta Med Scand. 1986;220(5):419-24
     </refsource>
     <pmid version="1">
      3544690
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      JAMA. 1988 Apr 1;259(13):1976-82
     </refsource>
     <pmid version="1">
      3346979
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br Med J (Clin Res Ed). 1986 Nov 1;293(6555):1145-51
     </refsource>
     <pmid version="1">
      3094811
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Hypertens. 1987 Oct;5(5):561-72
     </refsource>
     <pmid version="1">
      2892881
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Hypertens. 1985 Aug;3(4):379-92
     </refsource>
     <pmid version="1">
      2864374
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br Med J (Clin Res Ed). 1985 Jul 13;291(6488):97-104
     </refsource>
     <pmid version="1">
      2861880
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 1999 Feb 20;353(9153):611-6
     </refsource>
     <pmid version="1">
      10030325
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      JAMA. 1999 May 26;281(20):1927-36
     </refsource>
     <pmid version="1">
      10349897
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 1999 Nov 20;354(9192):1751-6
     </refsource>
     <pmid version="1">
      10577635
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 2000 Jul 29;356(9227):359-65
     </refsource>
     <pmid version="1">
      10972367
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Intern Med. 2001 Apr 3;134(7):550-60
     </refsource>
     <pmid version="1">
      11281737
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 2002 Mar 23;359(9311):995-1003
     </refsource>
     <pmid version="1">
      11937178
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Circulation. 2002 Nov 5;106(19):2422-7
     </refsource>
     <pmid version="1">
      12417537
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      JAMA. 2002 Nov 20;288(19):2421-31
     </refsource>
     <pmid version="1">
      12435255
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Hypertens. 2002 Dec;15(12):1096-100
     </refsource>
     <pmid version="1">
      12460707
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Hypertens. 2002 Dec;15(12):1101-8
     </refsource>
     <pmid version="1">
      12460708
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      JAMA. 2003 Apr 23-30;289(16):2073-82
     </refsource>
     <pmid version="1">
      12709465
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      JAMA. 2003 May 21;289(19):2534-44
     </refsource>
     <pmid version="1">
      12759325
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Hypertens. 2003 Jun;21(6):1055-76
     </refsource>
     <pmid version="1">
      12777939
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Hypertens. 1992 Jun;5(6 Pt 2):182S-189S
     </refsource>
     <pmid version="1">
      1352979
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      BMJ. 1992 Feb 15;304(6824):405-12
     </refsource>
     <pmid version="1">
      1445513
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 2003 Nov 8;362(9395):1527-35
     </refsource>
     <pmid version="1">
      14615107
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      JAMA. 2003 Dec 3;290(21):2805-16
     </refsource>
     <pmid version="1">
      14657064
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 2005 Sep 10-16;366(9489):895-906
     </refsource>
     <pmid version="1">
      16154016
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 2005 Oct 29-Nov 4;366(9496):1510-2
     </refsource>
     <pmid version="1">
      16257329
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 2005 Oct 29-Nov 4;366(9496):1545-53
     </refsource>
     <pmid version="1">
      16257341
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 2006 Jan 21;367(9506):208; author reply 210
     </refsource>
     <pmid version="1">
      16427485
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 1991 Nov 23;338(8778):1281-5
     </refsource>
     <pmid version="1">
      1682683
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 1990 Apr 7;335(8693):827-38
     </refsource>
     <pmid version="1">
      1969567
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      CMAJ. 2007 Mar 27;176(7):971; author reply 971-2
     </refsource>
     <pmid version="1">
      17389448
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      J Fam Pract. 2008 Jan;57(1):18-21
     </refsource>
     <pmid version="1">
      18171564
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      CMAJ. 2007 Mar 27;176(7):971; author reply 971-2
     </refsource>
     <pmid version="1">
      17389449
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      CMAJ. 2007 Mar 27;176(7):971; author reply 971-2
     </refsource>
     <pmid version="1">
      17389450
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      ACP J Club. 2006 Nov-Dec;145(3):60
     </refsource>
     <pmid version="1">
      17080972
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      Evid Based Med. 2006 Dec;11(6):168
     </refsource>
     <pmid version="1">
      17213162
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="ErratumIn">
     <refsource>
      CMAJ. 2007 Mar 27;176(7):976
     </refsource>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adrenergic beta-Antagonists
     </descriptorname>
     <qualifiername majortopicyn="Y">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adult
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Age Factors
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Cardiovascular Diseases
     </descriptorname>
     <qualifiername majortopicyn="N">
      etiology
     </qualifiername>
     <qualifiername majortopicyn="N">
      prevention &amp; control
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Hypertension
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug therapy
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Middle Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Placebos
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Randomized Controlled Trials as Topic
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Stroke
     </descriptorname>
     <qualifiername majortopicyn="N">
      etiology
     </qualifiername>
     <qualifiername majortopicyn="N">
      prevention &amp; control
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Treatment Outcome
     </descriptorname>
    </meshheading>
   </meshheadinglist>
   <otherid source="NLM">
    PMC1471831
   </otherid>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      2006
     </year>
     <month>
      6
     </month>
     <day>
      7
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      2006
     </year>
     <month>
      6
     </month>
     <day>
      9
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      2006
     </year>
     <month>
      6
     </month>
     <day>
      7
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pii">
     174/12/1737
    </articleid>
    <articleid idtype="doi">
     10.1503/cmaj.060110
    </articleid>
    <articleid idtype="pubmed">
     16754904
    </articleid>
    <articleid idtype="pmc">
     PMC1471831
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

